BLUE: bluebird bio, Inc. Stock

by  •  • Comments Off on BLUE: bluebird bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 48.66
Enterprise Value ($M) 71.45
Book Value ($M) -57.87
Book Value / Share -5.91
Price / Book -0.84
NCAV ($M) -179.30
NCAV / Share -18.31
Price / NCAV -0.27

Profitability (mra)
Return on Invested Capital (ROIC) -1.26
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.29
Current Ratio 0.55

Balance Sheet (mrq) ($M)
Current Assets 174.52
Assets 295.96
Liabilities 353.82
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 83.81
Operating Income -267.70
Net Income -240.72
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -260.02
Cash from Investing 3.90
Cash from Financing 87.47

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Granahan Investment Management Inc/ma 0.00 -100.00
11-14 13G/A Alyeska Investment Group, L.P. 0.00 -100.00
11-13 13G/A Vanguard Group Inc 5.40 0.00
11-12 13G/A Goldman Sachs Group Inc 1.10 -81.99
11-08 13G BlackRock, Inc. 8.00 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-09-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-09-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-09-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-16 27,073 546,875 4.95
2025-05-15 25,548 658,260 3.88
2025-05-14 421,370 5,319,284 7.92

(click for more detail)

Similar Companies
BDTX – Black Diamond Therapeutics, Inc. BEAM – Beam Therapeutics Inc.
BIIB – Biogen Inc. BMEA – Biomea Fusion, Inc.
BMRN – BioMarin Pharmaceutical Inc.


Financial data and stock pages provided by
Fintel.io